Intramedullary Tumor Management in Spinal Cord Systems

Intramedullary spinal cord tumours constitute a rare but clinically significant subset of central nervous system neoplasms, arising within the substance of the cord itself. Management begins with detailed magnetic resonance imaging to delineate lesion extent, morphological features and relationship to adjacent neural tracts. Intraoperative neurophysiological monitoring guides microsurgical resection, where the goal is maximal safe removal—ideally gross total resection—to minimise recurrence while preserving neurological function. Subtotal resection may be employed when a clear resection plane is lacking, particularly in infiltrative astrocytomas. Adjuvant therapies, including radiotherapy and chemotherapy, are considered selectively for high-grade lesions or residual tumour. Advances in diffusion tensor imaging and tractography have refined preoperative planning, and prediction models based on imaging parameters now assist in differential diagnosis. Long-term functional outcome and quality of life remain central, with rehabilitation and multidisciplinary follow-up essential for vocational and physical reintegration. Emerging work on patient-reported outcomes and decision-making tools highlights a shift towards personalised management strategies reflecting both oncological control and everyday well-being.

Research from Nature Portfolio

A novel prediction model has been developed to distinguish spinal myxopapillary ependymoma from schwannoma on preoperative MRI. By analysing features such as intratumoral T2 dark signals, subarachnoid haemorrhage, leptomeningeal seeding and patterns of contrast enhancement, multivariable logistic regression produced a tool with excellent discriminatory performance (AUC >0.92). This approach promises more accurate surgical planning and may reduce unnecessary sampling or delay in definitive treatment.

Investigators have also examined long-term quality of life and return to work following spinal ependymoma resection. Despite predominantly mild postoperative neurological deficits, a majority of patients reported ongoing pain, coordination issues and limitations in physical activities even five years after surgery. The study revealed a shift from full-time to part-time employment and emphasised that conventional clinical scales may under-represent patient-perceived impairment, underscoring the need for cord-specific outcome measures and tailored rehabilitation programmes.

Intramedullary Tumor Management in Spinal Cord Systems publication trend

The graph below shows the total number of articles in intramedullary tumor management in spinal cord systems across all publications each year (not limited to Nature Index journals).

Technical terms

Intramedullary tumour: A neoplasm located within the spinal cord parenchyma.

Gross total resection (GTR): Surgical removal of all visible tumour tissue.

Subtotal resection: Intentional partial removal of tumour when complete excision risks neurological damage.

Myxopapillary ependymoma: A slow-growing, grade I ependymal tumour typically affecting the lumbosacral region.

Intraoperative neurophysiological monitoring: Real-time assessment of spinal cord function using evoked potentials to minimise surgical injury.

Progression-free survival: The interval during which a patient’s tumour shows no radiological or clinical evidence of growth.

References

1. Long-Term Outcomes after Incomplete Resection of Intramedullary Grade II Ependymomas: Is Adjuvant Radiotherapy Justified?. Cancers (2023).
2. Development of a novel prediction model for differential diagnosis between spinal myxopapillary ependymoma and schwannoma. Scientific Reports (2024).
3. Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions. Insights into Imaging (2018).
4. Surgical Treatment of Intra- and Juxtamedullary Spinal Cord Tumors: A Population Based Observational Cohort Study. Frontiers in Neurology (2019).
5. Quality of life and return to work and sports after spinal ependymoma resection. Scientific Reports (2022).